An interventional study of Laparoscopic transabdominal preperitoneal hernia repair. and Lichtenstein hernia repair. in Inguinal Hernia, sponsored by Second Hospital of Jilin University. Completed at 1 site in China. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-06.
Sponsored by Second Hospital of Jilin University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Hernia, Inguinal with a site in China — 5 open to participants now, 5 under way, none of them phase 3. Hernia, Inguinal · China.
Among the 27 studies in Hernia, Inguinal with a site in China, this one is the 12th largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2022, is one of 20 with no phase, and was the 20th registered.
545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.
Browse Hernia, Inguinal studies →5 of the 27 studies in Hernia, Inguinal with a site in China are open now. Recruiting first, the newest first:
Nanchong Central Hospital · Sites in China
Ages 18+ · Women only
The Second Affiliated Hospital of Kunming Medical University · Sites in China
Ages 18–80
Xiangya Hospital of Central South University · Sites in China
Ages up to 14
Nanchong Central Hospital · Sites in China
Ages 18–80
Xiangya Hospital of Central South University · Sites in China
Ages 18–80
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 1 · Phase 4 1
First in 2000; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 130 is above the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 117 across the 24 interventional studies, 300 across the 3 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 27 have an industry lead sponsor. The 10 most frequent:
Second Hospital of Jilin University is the lead sponsor of 17 studies on the registry; 3 are open to participants now.
Second Hospital of Jilin University has 2 studies filed under Hernia, Inguinal — fewer than ten, so there is no comparison to draw.
1 of the studies in Hernia, Inguinal with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07936981Xiangya Hospital of Central South UniversityPain Assessment After Pediatric Indirect Inguinal Hernia Surgery | 2027-10-30 |
Add it to your calendar (.ics) → With an account.
Among the 27 studies in Hernia, Inguinal with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this prospective study is to compare the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair, in order to improve the outcome of inguinal hernia treatment. The main question it aims to answer is, in which procedure is the self-gripping mesh more effective.
Participants will be divided into the TAPP group and the Lichtenstein group by random number table method, the TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair, and the Lichtenstein group underwent Lichtenstein hernia repair, both groups used self-gripping meshes.
Researchers will compare the operation time, postoperative time out of bed, postoperative hospital stay, hospital costs and postoperative complications between the two groups to see the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair.
Procedure: Laparoscopic transabdominal preperitoneal hernia repair.
The Lichtenstein group underwent Lichtenstein hernia repair.
Procedure: Lichtenstein hernia repair.
The TAPP group used self-gripping mesh for laparoscopic transperitoneal preperitoneal hernia repair.
The Lichtenstein group used self-gripping mesh for Lichtenstein hernia repair.
Incidence of moderate to severe pain at 3 and 6 months after surgery.
Visual analogue scale (VAS) was used to score the postoperative pain at 3 and 6 months. The score ranges from 0 (no pain) to 10 (most severe pain).
Time frame: 3 and 6 months after surgery.
Incidence of recurrent inguinal hernia at 3 and 6 months after surgery.
Recurrence of inguinal hernia after surgery
Time frame: 3 and 6 months after surgery.
Plan to share: No — Data sharing with other researchers is not planned at this time due to patient privacy concerns.
No publications or documents are linked to this record.
Ran from Mar 2022 to primary completion in Nov 2023, 20 months.
Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 20 months is close to that.
Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Hospital of Jilin University